ArticleEClinicalMedicine2024

Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study.

Zhihao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.